RETA · Categories · Form 4

RETA - SEC Form 4 insider transactions

Reata Pharmaceuticals Inc. (RETA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for RETA

• 985d
  Desai Antal Rohit returned 2,928,368 shares to the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Mcgaughy R Kent Jr returned 2,926,776 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Wortley Michael D returned 49,701 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Oliger Christy J. returned 5,565 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Ryder Steven returned 10,907 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Rose William returned 599,583 shares to the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Soni Manmeet Singh returned 62,621 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Loewen Andrea returned 28,416 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Huff James Warren returned 132,878 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Ruff Shamim returned 7,359 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Meyer Colin John returned 81,633 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Patni Rajiv returned 45,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Mcclellan William D. Jr. returned 6,017 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Bir Dawn Carter returned 33,805 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Edwards Martin returned 6,116 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 987d
  Anand Bhaskar returned 24,089 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 994d
  SEC Form 4 filed by Rose William

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 995d
  SEC Form 4: Loewen Andrea sold $546,181 worth of shares (3,175 units at $172.03), decreasing direct ownership by 10% to 28,416 units

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1006d
  SEC Form 4: Anand Bhaskar sold $68,695 worth of shares (406 units at $169.20), decreasing direct ownership by 2% to 24,089 units

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1020d
  SEC Form 4: Rose William gifted 500,000 shares

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1027d
  SEC Form 4: Wortley Michael D sold $203,581 worth of shares (1,205 units at $168.95), decreasing direct ownership by 2% to 49,701 units

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1027d
  SEC Form 4: Soni Manmeet Singh sold $295,566 worth of shares (1,755 units at $168.41), decreasing direct ownership by 3% to 62,621 units

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1027d
  SEC Form 4: Meyer Colin John sold $463,052 worth of shares (2,740 units at $169.00), decreasing direct ownership by 3% to 81,633 units

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1027d
  SEC Form 4: Bir Dawn Carter sold $203,409 worth of shares (1,205 units at $168.80), decreasing direct ownership by 3% to 33,805 units

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1027d
  SEC Form 4: Anand Bhaskar sold $67,995 worth of shares (403 units at $168.72), decreasing direct ownership by 2% to 24,495 units

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1043d
  SEC Form 4: Soni Manmeet Singh converted options into 75,000 shares and sold $12,346,298 worth of shares (75,000 units at $164.62)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1043d
  SEC Form 4: Ruff Shamim exercised 8,235 shares at a strike of $92.20 and sold $1,354,887 worth of shares (8,235 units at $164.53)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1043d
  SEC Form 4: Mcclellan William D. Jr. converted options into 5,000 shares and sold $822,442 worth of shares (5,000 units at $164.49)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1043d
  SEC Form 4: Bir Dawn Carter converted options into 40,000 shares and sold $6,581,428 worth of shares (40,000 units at $164.54)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1065d
  SEC Form 4 filed by Wortley Michael D

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1065d
  SEC Form 4 filed by Soni Manmeet Singh

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1065d
  SEC Form 4 filed by Meyer Colin John

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1065d
  SEC Form 4 filed by Bir Dawn Carter

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1065d
  SEC Form 4 filed by Huff James Warren

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1089d
  SEC Form 4 filed by Anand Bhaskar

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1091d
  SEC Form 4 filed by Soni Manmeet Singh

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1091d
  SEC Form 4 filed by Patni Rajiv

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1096d
  SEC Form 4 filed by Rose William

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1096d
  SEC Form 4 filed by Ryder Steven

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1096d
  SEC Form 4 filed by Ruff Shamim

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1096d
  SEC Form 4 filed by Mcgaughy R Kent Jr

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1096d
  SEC Form 4 filed by Oliger Christy J.

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1096d
  SEC Form 4 filed by Mcclellan William D. Jr.

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1096d
  SEC Form 4 filed by Edwards Martin

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1119d
  SEC Form 4 filed by Wortley Michael D

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1119d
  SEC Form 4 filed by Soni Manmeet Singh

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1119d
  SEC Form 4 filed by Meyer Colin John

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1119d
  SEC Form 4 filed by Khan Samina

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1119d
  SEC Form 4 filed by Anand Bhaskar

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1119d
  SEC Form 4 filed by Bir Dawn Carter

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1120d
  SEC Form 4 filed by Loewen Andrea

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1127d
  SEC Form 4 filed by Soni Manmeet Singh

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1182d
  SEC Form 4: Bir Dawn Carter sold $808,436 worth of shares (9,317 units at $86.77), decreasing direct ownership by 22% to 32,196 units

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1184d
  SEC Form 4: Ruff Shamim exercised 5,740 shares at a strike of $34.50 and sold $480,610 worth of shares (5,740 units at $83.73)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1188d
  SEC Form 4: Loewen Andrea exercised 15,000 shares at a strike of $27.32 and sold $1,588,137 worth of shares (19,036 units at $83.43), decreasing direct ownership by 9% to 38,757 units

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1189d
  SEC Form 4: Bir Dawn Carter converted options into 90,000 shares and sold $8,503,621 worth of shares (96,996 units at $87.67), decreasing direct ownership by 14% to 41,513 units

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1189d
  SEC Form 4: Anand Bhaskar sold $13,956 worth of shares (165 units at $84.58), decreasing direct ownership by 0.61% to 26,765 units (withholding tax)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1189d
  SEC Form 4: Meyer Colin John sold $52,518 worth of shares (621 units at $84.57), decreasing direct ownership by 0.73% to 84,606 units (tax liability)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1189d
  SEC Form 4: Soni Manmeet Singh sold $52,680 worth of shares (622 units at $84.69), decreasing direct ownership by 0.70% to 88,304 units to satisfy tax liability

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)
• 1189d
  SEC Form 4: Wortley Michael D sold $34,966 worth of shares (414 units at $84.46), decreasing direct ownership by 0.85% to 48,092 units (tax liability)

  4 - REATA PHARMACEUTICALS INC (0001358762) (Issuer)

Other RETA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends